Prescribed GHK-Cu · A research bulletin
Outside the cell, a different GHK-Cu story
Prescribed suggests putting something in. A nerve-cell experiment with free GHK found protection by holding copper outside. The location of the metal changes the story.
A bulletin on GHK-Cu and the places copper goes.
Nerve cells in a dish
In a 2024 experiment with nerve cells and their support cells, free GHK prevented metal-related protein clumping and cell death. The important action happened outside the cells: GHK bound extracellular copper and blocked its accumulation inside. This was laboratory work with cells, with no patients receiving treatment.
I had pictured copper delivery. This experiment introduced a more surprising job: holding it back. The preparation started with GHK, the copper-free peptide, rather than GHK-Cu. That identity matters just as much as the protection the researchers observed.
For a site called Prescribed GHK-Cu, this seems an excellent complication. A clinical-sounding name encourages a simple picture of giving a substance and receiving a benefit. The cell experiment sends the question somewhere more interesting: where does the copper need to be?
Copper outside the cell
The nerve-cell study examined copper- and zinc-induced protein aggregation and cell death. GHK completely prevented the tested copper-induced DLAT aggregation, a measure of copper-related protein clumping. Its copper-sequestering action—binding the metal where it was available outside the cell—gave the finding a specific mechanism.
That location interests me. A phrase such as antioxidant can gather several quite different processes under one comforting word. Here the explanation involved copper being prevented from accumulating inside the cells. The experiment leaves human neurological treatment, tissue distribution and clinical safety untested.
I would be curious to see whether the same protective behavior survives the conditions of a living body. For now, the dish contains the result and its boundaries.
Copper-bound GHK in fibroblasts
GHK is glycine, histidine and lysine joined as a tripeptide. GHK-Cu carries bound copper; Copper Tripeptide-1 is its cosmetic ingredient name. The skin-regeneration review describes the peptide and copper complex across repair research.
In fibroblasts, the cells that make skin's supporting material, GHK-Cu increased MMP-2 expression while free GHK failed to reproduce that response. MMP-2 helps remove old supporting tissue during remodeling. Proteins that restrain that process increased too. This comparison concerns cells in culture.
I like these experiments better together. A copper-bound complex has a useful role in the fibroblast result; free GHK has a copper-sequestering role in the nerve-cell result. The evidence gives each preparation a particular task. It offers no reason to treat their names as interchangeable.
Skin, plasma and tissue
The location question continues at the skin. In an excised-human-skin experiment, copper applied as a GHK-Cu complex entered the dermis and remained there over 48 hours; the reported retained amount was 97 micrograms per square centimeter. That study measured copper in removed tissue.
The nearest plasma metabolism experiment followed free GHK in rats, where it rapidly became the smaller peptide HK. Human systemic GHK-Cu still lacks validated half-life and tissue-distribution measurements. The two studies follow different substances through different places.
These locations give the bulletin its bearings: copper held outside cultured nerve cells, copper bound in a repair complex, copper retained in skin. The experiments, skin studies and exposure notes follow those distinctions. I prefer that unsettled geography to a promise that every extra bit of copper must be helpful.